Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples